Levofloxacin Beximco (Levofloxacin)

Levofloxacin works by inhibiting two essential bacterial enzymes: DNA gyrase and topoisomerase IV. These enzymes are required for DNA replication and transcription. By binding to them, levofloxacin prevents bacterial DNA from unwinding and replicating, which stops bacterial cell division and leads to bacterial death, providing a bactericidal effect against a broad range of pathogens.

The dosage of Levofloxacin Beximco is determined by the prescribing clinician based on the specific infection, patient age, renal function, and other clinical factors. Healthcare providers select the appropriate strength, frequency, and duration to achieve optimal therapeutic outcomes while minimizing the risk of adverse effects.

Levofloxacin is classified as pregnancy category unknown, and its safety has not been fully established for pregnant or nursing women. It should only be used if the potential benefits to the mother outweigh any possible risks to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After validation, the sales team will provide pricing, availability, shipping details (including any cold‑chain requirements), and assist with import documentation.

Levofloxacin is a third‑generation fluoroquinolone with a broad spectrum of activity against both Gram‑positive and Gram‑negative bacteria. Compared with older agents like ciprofloxacin, levofloxacin often offers improved dosing convenience (once‑daily regimens) and enhanced activity against respiratory pathogens. However, safety considerations such as tendon toxicity and QT prolongation are shared across the class.

Levofloxacin Beximco should be stored at temperatures below 25 °C (77 °F). Keep the product in its original packaging to protect it from moisture and direct sunlight. Do not store in areas with high humidity or extreme heat, as these conditions could affect tablet integrity.

Levofloxacin Beximco is administered orally, typically as a tablet taken with or without food. Patients should swallow the tablet whole with a full glass of water and follow the prescribing clinician’s instructions regarding timing and any necessary dose adjustments.

Serious risks include tendon rupture (especially in the Achilles tendon), QT interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, and peripheral neuropathy. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, severe rash, or neurological symptoms.

Levofloxacin Beximco should be avoided in individuals with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, patients with significant QT prolongation, and patients receiving concurrent medications that may cause serious drug interactions unless closely monitored.